The Hospitals and Clinics Segment to Dominate Asia Pacific Holter ECG Market during 2021-2028

According to a new market research study on “Asia Pacific Holter ECG Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast – by Component, End User and Country,” is expected to reach US$ 238.62 million by 2028 from US$ 130.10 million in 2021. The market is estimated to grow at a CAGR of 9.1% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific holter ECG market along with the drivers and restraints pertaining to the market growth. Rise in the Instances of cardiovascular diseases (CVDs) and growing elderly population are major factors driving the growth of the Asia Pacific holter ECG market. However, limited qualified professionals leading to inaccurate holter ecg analysis may hinder the growth of Asia Pacific holter ECG market.

According to the WHO, as the COVID-19 affected many countries in Asia Pacific, continuous measures were taken by country governments to curb the disease spread; in addition, other measures taken with the same purpose have disturbed the harmony of international travel and trade activities. Countries such as Japan and Australia are conducting virtual international conferences to predict the impact of COVID-19 on the medical device industry in Asia Pacific. The pandemic has led to disruptions in supply chains, loss of revenue, and disruptions in marketing and sales activities, further restraining the holter ECG market progress. On the other hand, unlike North America and Europe, many Asian countries did not impose the second lockdown. Hence, businesses in these countries started recovering gradually. Moreover, portable home diagnostic devices and electrocardiogram (ECG) devices are gaining traction among family physicians and patients for early and accurate diagnosis, which benefits by eliminating the need for stepping out of their houses, unless there is a medical emergency.   

The market for Asia Pacific holter ECG is segmented into component, end user and country. Based on component, the market is segmented into wired holter monitors, wireless holter monitors, and holter analysis systems & software. In 2021, the wired holter monitors segment held the largest share in Asia Pacific holter ECG market. Based on end user, the Asia Pacific holter ECG market is segmented into hospitals & clinics, home settings, ambulatory surgical centers, and other end users. The home settings segment is expected to be the fastest growing segment over the forecast period. Based on country, the Asia Pacific holter ECG market is segmented into Japan, China, India, Australia, South Korea and rest of Asia Pacific. In 2021, Japan held the largest share in Asia Pacific holter ECG market. Furthermore, in this present scenario of COVID 19 pandemic, the Asia Pacific holter ECG market has been facing difficulties and several countries have suffered heavily. The manufacturing sectors in the Asia Pacific countries have been experiencing low production and a weak supply chain. Thereby, impacting the market for holter ECG.

BPL Medical Technologies, Fukuda Denshi, General Electric, Koninklijke Philips N.V., Nihon Kohden Corporation, OSI Systems, Inc., Schiller Healthcare India Pvt. Ltd., Viatom Technology Co., Ltd. and Hill Rom Holding Inc. are some of the leading companies in the Asia Pacific holter ECG market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com